Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS)
| Autor: | Saeed Farooq, Farooq Naeem, Ejaz Gul, Zahid Nazar, Uma M. Irfan, Javed Akhter, Muhammad Irfan |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Global Assessment of Functioning law.invention Medication Adherence 03 medical and health sciences Young Adult 0302 clinical medicine Randomized controlled trial Ambulatory care law Intervention (counseling) medicine Ambulatory Care Humans Pakistan 030212 general & internal medicine Young adult Psychiatry Developing Countries Intention-to-treat analysis Positive and Negative Syndrome Scale business.industry Middle Aged medicine.disease Long-Term Care 030227 psychiatry Intention to Treat Analysis Psychiatry and Mental health Treatment Outcome Caregivers Schizophrenia Physical therapy Female Schizophrenic Psychology business Antipsychotic Agents Program Evaluation |
| Zdroj: | The British journal of psychiatry : the journal of mental science. 199(6) |
| ISSN: | 1472-1465 |
| Popis: | BackgroundMost people with schizophrenia in low- and middle-income (LAMI) countries receive minimal formal care, and there are high rates of non-adherence to medication.AimsTo evaluate the effectiveness of an intervention that involves a family member in supervising medication administration – supervised treatment in out-patients for schizophrenia (STOPS) – in improving treatment adherence and clinical outcomes.MethodIndividuals (n = 110) with schizophrenia or schizoaffective disorders were allocated to STOPS or to treatment as usual (TAU) and followed up for 1 year. The primary outcome was adherence to the treatment regimen. Positive and Negative Syndrome Scale for Schizophrenia and Global Assessment of Functioning scores were also assessed.ResultsParticipants in the STOPS group had better adherence (complete adherence: 37 (67.3%) in STOPS v. 25 (45.5%) in TAU; PConclusionsSTOPS may be useful in enhancing adherence to treatment for schizophrenia in LAMI countries. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|